415 Capital

What they do

415 Capital is a specialist venture capital firm focused on funding breakthrough and life-saving medical innovation. The firm provides entrepreneurs with capital, expertise, and market access and has funded over 50 medical technology companies, with more than 25 realized exits via trade sales and IPOs. Its active portfolio includes clinical-stage companies developing technologies such as next-generation clot removal platforms, AI-powered cardiovascular robotics and imaging, and percutaneous ventricular assist devices.

What they look for

415 Capital exclusively invests in technologies that address large unmet patient needs in chronic diseases, with a heavy emphasis on cardiovascular and neurovascular disorders-the leading causes of death globally and the largest cost drivers in healthcare. Their mission is to improve patient outcomes and quality of life at lower long-term healthcare costs.

Stage

Series A, Series B+

Sectors

Healthcare, Deeptech, AI

Based

Munich, DE